Specific TCR profiles predict clinical outcome of adjuvant EGFR-TKIs for resected EGFR-mutant non-small cell lung cancer

• Váldodahkkit: Si-Yang Maggie Liu (Dahkki), Cunte Chen (Dahkki), Yi-Kai Zhang (Dahkki), Wen-Zhao Zhong (Dahkki), Yi-Long Wu (Dahkki), Si-Yang Liu (Dahkki), Yangqiu Li (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2023-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background ADJUVANT-CTONG1104 reported a favorable survival outcome from adjuvant gefitinib treatment over chemotherapy in EGFR-mutant non-small cell lung cancer (NSCLC) patients. However, heterogeneous benefit from EGFR-TKIs and chemotherapy demands further biomarker exploration for patien...